VR Logo

Parnax Lab Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1982

Chairman: Prakash M Shah

Managing Director: Baiju M Shah

Group: --

Listing: BSE: 506128

Headquarters: Mumbai, Maharashtra

Website: www.naxparlab.com

Key Facts

Market cap: R 15.65 Cr

Revenue (TTM): R 91.96 Cr

Earnings (TTM): R -1.09 Cr

Cash: R 0.60 Cr

Total Debt: R 41.94 Cr

Promoters' ownership: 62.59%

Liquidity: Low

52 Week range: R 11.65 - 31.00

Face value: R10.00

Shares outstanding: 85,04,866

10 Years Aggregate:

  • CFO: 43.90 Cr
  • EBITDA: 70.33 Cr
  • Net Profit: 16.15 Cr

Stock Performance

Time Period Parnax Lab Ltd. S&P BSE Healthcare* S&P BSE Small Cap*
YTD8.2416.51-20.49
1 month-5.202.05-1.88
3 months31.4316.07-20.54
1 Year-36.3917.60-26.73
3 Years-31.724.88-10.29
5 Years-7.65-1.53-0.70
10 Years--11.042.45
As on 01-Jun-2020 *As on 29-May-2020
Year Parnax Lab Ltd. S&P BSE Small Cap S&P BSE Healthcare
2019-62.26-6.85-3.55
2018-24.90-23.41-5.89
201787.4259.640.49
2016-47.421.77-12.88
201585.626.7615.06
2014-42.2069.2447.43
2013-11.46-11.2322.55